Editas Medicine, Inc.EDITNASDAQ
Loading
Year-over-year book value per share growth
Latest
105.91%
↑ 1660% vs avg
Percentile
P97
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
6.02%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 105.91% |
| Q3 2025 | -34.31% |
| Q2 2025 | -69.75% |
| Q1 2025 | -53.76% |
| Q4 2024 | -23.67% |
| Q3 2024 | -24.46% |
| Q2 2024 | -21.55% |
| Q1 2024 | -15.90% |
| Q4 2023 | -3.23% |
| Q3 2023 | -21.20% |
| Q2 2023 | 21.64% |
| Q1 2023 | -12.15% |
| Q4 2022 | -13.11% |
| Q3 2022 | -11.01% |
| Q2 2022 | -9.73% |
| Q1 2022 | -7.26% |
| Q4 2021 | -5.84% |
| Q3 2021 | -4.81% |
| Q2 2021 | -6.53% |
| Q1 2021 | 52.69% |
| Q4 2020 | -10.81% |
| Q3 2020 | -7.94% |
| Q2 2020 | 79.46% |
| Q1 2020 | -16.22% |
| Q4 2019 | 21.68% |
| Q3 2019 | 7.13% |
| Q2 2019 | -11.52% |
| Q1 2019 | -9.61% |
| Q4 2018 | 3.92% |
| Q3 2018 | -3.92% |
| Q2 2018 | -8.45% |
| Q1 2018 | 10.16% |
| Q4 2017 | 13.50% |
| Q3 2017 | -5.01% |
| Q2 2017 | -19.93% |
| Q1 2017 | 50.21% |
| Q4 2016 | -21.40% |
| Q3 2016 | -9.72% |
| Q2 2016 | -6.42% |
| Q1 2016 | 343.68% |